CXCL8 and psoriasis: Surprisingly, MTX, which is the drug of choice for conventional psoriasis treatment, exhibited rather weak inhibitory effects on the tested inflammatory cytokines in HaCaT cells, with the biggest impact (as much as three times more potent than genistein) only on IL-8 when cells were treated with TNF-α.